Autoimmune diseases, immune modulation, inflammation, and self-tolerance
203 articles
New study shows 84% of RA patients can discontinue prednisolone after short-term use, supporting safer treatment approaches.
Researchers discuss anifrolumab as potential second-line treatment for childhood lupus when belimumab doesn't work.
Scientists discover how defective gene splicing in neutrophils contributes to lupus severity and immune dysfunction.
Monitoring IgG protein levels during first year of treatment can predict which patients will experience disease relapse.
Case report reveals dangerous skin complications in rheumatoid arthritis patients that doctors need to recognize early.
New research reveals how IL-17 triggers inflammatory cascades that damage blood vessels in giant cell arteritis patients.
Researchers identify OGFRL1 gene deficiency as a novel cause of chronic bone disease, with promising treatment response to TNF inhibitors.
New clinical insights into treating Rowell syndrome, a rare skin manifestation affecting lupus patients with serious complications.
Revolutionary cell therapy achieves drug-free remission in patients with severe myasthenia gravis, an autoimmune muscle disorder.
Systematic review reveals younger RA patients achieve higher remission rates and better outcomes with biologic therapies than older patients.
Real-world study reveals sarilumab and JAK inhibitors work equally well for rheumatoid arthritis, but sarilumab causes fewer infections.
JAK inhibitors outperform traditional treatments for rheumatoid arthritis but carry cardiovascular and infection risks.
